Boulder Peptide Foundation (EIN 834670530) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2020

Legal Domicile

Principal Officer

Yvonne Angell

Phone

4087682218

Tax Period

2024-01-01 to 2024-12-31

Boulder Peptide Foundation, founded in 2020, is a small nonprofit in the Medical Research sector that reported $386K in total revenue in fiscal year 2024. Revenue grew 15% year-over-year, indicating healthy expansion. The organization ran a surplus of $69K, a strong 18% operating margin.

Mission

Organization was established to further the science and knowledge of peptide technology to develop novel therapeutics, biomaterials, medical diagnostics and other beneficial uses of mankind.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $128,474

Program Service Revenue $257,257

Investment Income $24

Other Revenue $0

TOTAL REVENUE $385,755

Expense Breakdown

Grants Paid $26,975

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $286,913

Other Expenses $289,597

TOTAL EXPENSES $316,572

Year-over-Year Comparison

	2024	2023	Change
Revenue	$385,755	$334,464	+0.2%
Expenses	$316,572	$331,504	0.0%
Net Income	$69,183	$2,960	+22.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Yvonne Angell	President	006.00	Officer Director	$0	$0	$0
Rebecca Nofsinger	Chair, Scientific Advisory Board	008.00	Officer Director	$0	$0	$0
Kevin McCowen	Treasurer	008.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$385,755	$316,572	$255,506	$69,183
2023	$329,589	$331,004	$109,038	$-1,415
2022	$315,662	$229,233	$107,000	$86,429

Boulder Peptide Foundation